|
PPM1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.24850171604407E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.55000481736079E-11 |
| Normal-vs-Stage2 |
1.96902999999304E-05 |
| Normal-vs-Stage3 |
3.964900E-04 |
| Normal-vs-Stage4 |
2.334100E-02 |
| Stage1-vs-Stage2 |
6.095800E-01 |
| Stage1-vs-Stage3 |
3.305600E-01 |
| Stage1-vs-Stage4 |
8.629200E-01 |
| Stage2-vs-Stage3 |
7.549600E-01 |
| Stage2-vs-Stage4 |
8.581000E-01 |
| Stage3-vs-Stage4 |
6.967400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.4646955283697E-12 |
| Normal-vs-AfricanAmerican |
2.0893999999938E-05 |
| Normal-vs-Asian |
8.582200E-01 |
| Caucasian-vs-AfricanAmerican |
2.310400E-01 |
| Caucasian-vs-Asian |
1.112070E-02 |
| AfricanAmerican-vs-Asian |
1.606220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62481139653892E-12 |
| Normal-vs-Female |
4.153900E-02 |
| Male-vs-Female |
1.89399999994677E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.35460000000509E-06 |
| Normal-vs-Extreme_Weight |
1.65534252971611E-12 |
| Normal-vs-Obese |
2.041999999991E-05 |
| Normal-vs-Extreme_Obese |
1.97508999999485E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.158430E-01 |
| Normal_Weight-vs-Obese |
5.641200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.969600E-01 |
| Extreme_Weight-vs-Obese |
1.423850E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.782600E-01 |
| Obese-vs-Extreme_Obese |
3.984600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.235600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.38500002974962E-09 |
| Normal-vs-Age(61-80Yrs) |
1.80910841862669E-12 |
| Normal-vs-Age(81-100Yrs) |
1.54940000052228E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.412400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.062200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.091770E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.094200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.458820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.663400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.19910764545739E-12 |
| Normal-VS-Type2 PRCC |
5.05529995642462E-09 |
| Normal-VS-KIRP CIMP |
7.820000E-01 |
| Normal-VS-Unclassified PRCC |
3.353500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.451600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.2599000000072E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.904400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.623590E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.726400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.183600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0736999955796E-08 |
| Normal-vs-N1 |
6.843600E-02 |
| Normal-vs-N2 |
9.016000E-02 |
| N0-vs-N1 |
2.336000E-02 |
| N0-vs-N2 |
3.278000E-01 |
| N1-vs-N2 |
8.809200E-01 |
|
|
